ABBV

SELL

AbbVie Inc.

Healthcare · Rank #276 · Analyzed Jul 13, 2026

$248.08

Current Price

$140.49

Intrinsic Value

low confidence

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueLow confidence — see rating

Fair Value Range

Low$59.96

Base (IV)$140.49

High$382.25

Entry Points

Conservative$41.97

Moderate$59.96

Aggressive$98.34

⚠️ Warnings

DCF/EPV diverge 5.0x — earnings power and cash flow disagree; fair value is low-confidence (blended conservatively)

Quality & Moat Breakdown

Return on Equity0.0% → 0/1.0

Debt LevelD/E 100 → 0/1.0

Revenue QualityGrowth 7.7%, margin Δ+2.7% +recovery → 1.0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins5.8% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.